Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

被引:83
|
作者
Guo, Charles C. [1 ]
Majewski, Tadeusz [1 ]
Zhang, Li [2 ]
Yao, Hui [3 ]
Bondaruk, Jolanta [1 ]
Wang, Yan [1 ]
Zhang, Shizhen [4 ]
Wang, Ziqiao [1 ]
Lee, June Goo [1 ]
Lee, Sangkyou [1 ]
Cogdell, David [1 ]
Zhang, Miao [1 ]
Wei, Peng [4 ]
Grossman, H. Barton [5 ]
Kamat, Ashish [5 ]
Duplisea, Jonathan James [5 ]
Ferguson, James Edward, III [5 ]
Huang, He [1 ]
Dadhania, Vipulkumar [1 ]
Gao, Jianjun [6 ]
Dinney, Colin [5 ]
Weinstein, John N. [3 ]
Baggerly, Keith [3 ]
McConkey, David [7 ]
Czerniak, Bogdan [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[7] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
来源
CELL REPORTS | 2019年 / 27卷 / 06期
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; UROTHELIAL CARCINOMA; MUTATIONAL PROCESSES; LUMINAL SUBTYPES; EXPRESSION; BREAST; PREDICTS; CHEMOTHERAPY; SIGNATURES; ALIGNMENT;
D O I
10.1016/j.celrep.2019.04.048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sarcomatoid urothelial bladder cancer (SARC) displays a high propensity for distant metastasis and is associated with short survival. We report a comprehensive genomic analysis of 28 cases of SARC and 84 cases of conventional urothelial carcinoma (UC), with the TCGA cohort of 408 muscleinvasive bladder cancers serving as the reference. SARCs show a distinct mutational landscape, with enrichment of TP53, RB1, and PIK3CA mutations. They are related to the basal molecular subtype of conventional UCs and could be divided into epithelial-basal and more clinically aggressive mesenchymal subsets on the basis of TP63 and its target gene expression levels. Other analyses reveal that SARCs are driven by downregulation of homotypic adherence genes and dysregulation of the EMT network, and nearly half exhibit a heavily infiltrated immune phenotype. Our observations have important implications for prognostication and the development of more effective therapies for this highly lethal variant of bladder cancer.
引用
收藏
页码:1781 / +
页数:17
相关论文
共 50 条
  • [1] Molecular profile of bladder cancer progression to clinically aggressive subtypes
    Guo, Charles C.
    Lee, Sangkyou
    Lee, June G.
    Chen, Huiqin
    Zaleski, Michael
    Choi, Woonyoung
    Mcconkey, David J.
    Wei, Peng
    Czerniak, Bogdan
    NATURE REVIEWS UROLOGY, 2024, 21 (07) : 391 - 405
  • [2] Progression to Sarcomatoid Bladder Cancer is Associated with Dysregulation of Chromatin Remodeling and Cell Cycle Circuits
    Guo, Charles
    Majewski, Tadeusz
    Zhang, Li
    Bondaruk, Jolanta
    Kamat, Ashish
    Dinney, Colin
    McConkey, David
    Czerniak, Bogdan
    LABORATORY INVESTIGATION, 2018, 98 : 346 - 346
  • [3] Progression to sarcomatoid bladder cancer is associated with dysregulation of chromatin remodelling and cell cycle circuits
    Guo, C.
    Majewski, T.
    Zhang, L.
    Bondaruk, J.
    Kamat, A.
    Dinney, C.
    McConkey, D.
    Czerniak, B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 612 - 612
  • [4] Progression to Sarcomatoid Bladder Cancer is Associated with Dysregulation of Chromatin Remodeling and Cell Cycle Circuits
    Guo, Charles
    Majewski, Tadeusz
    Zhang, Li
    Bondaruk, Jolanta
    Kamat, Ashish
    Dinney, Colin
    McConkey, David
    Czerniak, Bogdan
    MODERN PATHOLOGY, 2018, 31 : 346 - 346
  • [5] Dysregulation of Mucosal Microenvironment Drives the Progression of Urothelial Field Effects to Invasive Bladder Cancer
    Czerniak, Bogdan
    Lee, Sangkyou
    Jaksik, Roman
    Kus, Pawel
    Wang, Ziqiao
    Lee, June-Goo
    Navai, Neema
    Dinney, Colin
    McConkey, David
    Guo, Charles
    Wang, Wenyi
    Wei, Peng
    Kimmel, Marek
    LABORATORY INVESTIGATION, 2024, 104 (03) : S925 - S925
  • [6] Molecular Characterization of Clinically Aggressive Micropapillary Bladder Cancer
    Guo, Charles C.
    Dadhania, Vipulkumar
    Zhang, Li
    Bondaruk, Jolanta
    Majewski, Tadeusz
    Sykulski, Maciej
    Wronowska, Weronika
    Gambin, Anna
    Kamat, Ashish
    Dinney, Colin
    Choi, Woonyoung
    McConkey, David
    Weinstein, John
    Czerniak, Bogdan
    LABORATORY INVESTIGATION, 2016, 96 : 235A - 235A
  • [7] Molecular Characterization of Clinically Aggressive Micropapillary Bladder Cancer
    Guo, Charles C.
    Dadhania, Vipulkumar
    Zhang, Li
    Bondaruk, Jolanta
    Majewski, Tadeusz
    Sykuiski, Maciej
    Wronowska, Weronika
    Gambin, Anna
    Kamat, Ashish
    Dinney, Colin
    Choi, Woonyoung
    McConkey, David
    Weinstein, John
    Czerniak, Bogdan
    MODERN PATHOLOGY, 2016, 29 : 235A - 235A
  • [8] Expression of EMT Markers in Sarcomatoid Urothelial Carcinoma of the Bladder
    Sanfrancesco, J. M.
    Gupta, S.
    Shoskes, A.
    Lieser, G.
    Hansel, D.
    MODERN PATHOLOGY, 2013, 26 : 246A - 246A
  • [9] Expression of EMT Markers in Sarcomatoid Urothelial Carcinoma of the Bladder
    Sanfrancesco, J. M.
    Gupta, S.
    Shoskes, A.
    Lieser, G.
    Hansel, D.
    LABORATORY INVESTIGATION, 2013, 93 : 246A - 246A
  • [10] Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer
    Guo, Charles Chuanhai
    Dadhania, Vipulkumar
    Zhang, Li
    Majevvski, Tadeusz
    Bondaruk, Jolanta
    Sykulski, Maciej
    Wronowska, Weronika
    Gambin, Anna
    Wang, Yan
    Zhang, Shizhen
    Fuentes-Mattei, Enrique
    Kamat, Ashish Madhav
    Dinney, Colin
    Siefker-Radtke, Arlene
    Choi, Woonyoung
    Baggerly, Keith A.
    McConkey, David
    Weinstein, John N.
    Czerniak, Bogdan
    EUROPEAN UROLOGY, 2016, 70 (04) : 611 - 620